These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 221485)

  • 21. Structure-activity analysis of the activation of pertussis toxin.
    Kaslow HR; Lim LK; Moss J; Lesikar DD
    Biochemistry; 1987 Jan; 26(1):123-7. PubMed ID: 3030399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cysteine 41 of the A subunit of pertussis toxin.
    Burns DL; Manclark CR
    J Biol Chem; 1989 Jan; 264(1):564-8. PubMed ID: 2535846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAD-glycohydrolase activity of staphylococcal entertoxin A (SEA).
    Ezepchuk YuV ; Sysueva EG; Noscov AN
    Int J Biochem; 1981; 13(12):1269-71. PubMed ID: 6274722
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase.
    Moss J; Manganiello VC; Vaughan M
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4424-7. PubMed ID: 188038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities.
    Bortell R; Moss J; McKenna RC; Rigby MR; Niedzwiecki D; Stevens LA; Patton WA; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Aug; 167(4):2049-59. PubMed ID: 11489987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADP-ribosylarginine glycohydrolase catalyzing the release of ADP-ribose from the cholera toxin-modified alpha-subunits of GTP-binding proteins.
    Maehama T; Nishina H; Katada T
    J Biochem; 1994 Nov; 116(5):1134-8. PubMed ID: 7896743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NAD-dependent ADP-ribosylation of arginine and proteins by Escherichia coli heat-labile enterotoxin.
    Moss J; Garrison S; Oppenheimer NJ; Richardson SH
    J Biol Chem; 1979 Jul; 254(14):6270-2. PubMed ID: 221495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location and amino acid sequence around the ADP-ribosylation site in the cholera toxin active subunit A1.
    Lai CY; Xia QC; Salotra PT
    Biochem Biophys Res Commun; 1983 Oct; 116(1):341-8. PubMed ID: 6315008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand interactions of diphtheria toxin. I. Binding and hydrolysis of NAD.
    Lory S; Carroll SF; Bernard PD; Collier RJ
    J Biol Chem; 1980 Dec; 255(24):12011-5. PubMed ID: 6254990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12.
    Pearson GD; Mekalanos JJ
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2976-80. PubMed ID: 7045877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NAD-glycohydrolase activity of the pertussis toxin S1 subunit. Involvement of the catalytic HIS-35 residue.
    Antoine R; Locht C
    J Biol Chem; 1994 Mar; 269(9):6450-7. PubMed ID: 8119996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice.
    Watanabe K; Kato J; Zhu J; Oda H; Ishiwata-Endo H; Moss J
    PLoS One; 2018; 13(11):e0207693. PubMed ID: 30500844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.
    Dasgupta BR; Sugiyama H
    Infect Immun; 1976 Sep; 14(3):680-6. PubMed ID: 965092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholera toxin-catalysed ADP-ribosylation of erythrocyte proteins: general properties.
    Gill DM
    J Supramol Struct; 1979; 10(2):151-63. PubMed ID: 222965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymic, cysteine-specific ADP-ribosylation in bovine liver mitochondria.
    Jorcke D; Ziegler M; Herrero-Yraola A; Schweiger M
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):189-93. PubMed ID: 9576867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.
    Honda T; Finkelstein RA
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2052-6. PubMed ID: 109838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adenylate cyclase-activating activity of cholera toxin is not associated with a nicotinamide--adenine dinucleotide glycohydrolase activity.
    Tait RM; van Heyningen S
    Biochem J; 1978 Sep; 174(3):1059-62. PubMed ID: 215119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The primary structure of the COOH-terminal half of cholera toxin subunit A1 containing the ADP-ribosylation site.
    Xia QC; Chang D; Blacher R; Lai CY
    Arch Biochem Biophys; 1984 Nov; 234(2):363-70. PubMed ID: 6497377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polypeptide hormones and chromatin-associated proteins act as acceptors for cholera toxin-catalyzed ADP-ribosylation.
    Trepel JB; Chuang DM; Neff NH
    J Neurochem; 1981 Feb; 36(2):538-43. PubMed ID: 6257855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of cholera toxin by ADP-ribosylation factors.
    Moss J; Tsai SC; Vaughan M
    Methods Enzymol; 1994; 235():640-7. PubMed ID: 8057933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.